Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Assets (2016 - 2025)

SRx Health Solutions' Assets history spans 15 years, with the latest figure at $8.4 million for Q3 2025.

  • For Q3 2025, Assets fell 75.12% year-over-year to $8.4 million; the TTM value through Sep 2025 reached $8.4 million, down 75.12%, while the annual FY2025 figure was $8.4 million, N/A changed from the prior year.
  • Assets reached $8.4 million in Q3 2025 per SRXH's latest filing, down from $34.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $78.9 million in Q3 2021 to a low of $8.4 million in Q3 2025.
  • Average Assets over 5 years is $39.6 million, with a median of $34.0 million recorded in 2025.
  • The largest YoY upside for Assets was 159.72% in 2025 against a maximum downside of 75.12% in 2025.
  • A 5-year view of Assets shows it stood at $74.7 million in 2021, then crashed by 48.2% to $38.7 million in 2022, then tumbled by 56.73% to $16.7 million in 2023, then dropped by 5.59% to $15.8 million in 2024, then tumbled by 46.83% to $8.4 million in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Assets are $8.4 million (Q3 2025), $34.0 million (Q2 2025), and $15.3 million (Q1 2025).